306 related articles for article (PubMed ID: 27520326)
1. Ceftaroline as Salvage Monotherapy for Persistent MRSA Bacteremia.
Burnett YJ; Echevarria K; Traugott KA
Ann Pharmacother; 2016 Dec; 50(12):1051-1059. PubMed ID: 27520326
[TBL] [Abstract][Full Text] [Related]
2. Vancomycin plus ceftaroline for persistent methicillin-resistant Staphylococcus aureus bacteremia.
Kufel WD; Parsels KA; Blaine BE; Steele JM; Mahapatra R; Paolino KM; Thomas SJ
Pharmacotherapy; 2023 Jan; 43(1):15-23. PubMed ID: 36371648
[TBL] [Abstract][Full Text] [Related]
3. Ceftaroline for the treatment of methicillin-resistant
White BP; Barber KE; Stover KR
Am J Health Syst Pharm; 2017 Feb; 74(4):201-208. PubMed ID: 28179245
[TBL] [Abstract][Full Text] [Related]
4. Combination Therapy With Vancomycin and Ceftaroline for Refractory Methicillin-resistant Staphylococcus aureus Bacteremia: A Case Series.
Gritsenko D; Fedorenko M; Ruhe JJ; Altshuler J
Clin Ther; 2017 Jan; 39(1):212-218. PubMed ID: 28038791
[TBL] [Abstract][Full Text] [Related]
5. Methicillin-resistant Staphylococcus aureus bacteraemia and endocarditis treated with ceftaroline salvage therapy.
Ho TT; Cadena J; Childs LM; Gonzalez-Velez M; Lewis JS
J Antimicrob Chemother; 2012 May; 67(5):1267-70. PubMed ID: 22311935
[TBL] [Abstract][Full Text] [Related]
6. Ceftaroline fosamil monotherapy for methicillin-resistant Staphylococcus aureus bacteremia: a comparative clinical outcomes study.
Arshad S; Huang V; Hartman P; Perri MB; Moreno D; Zervos MJ
Int J Infect Dis; 2017 Apr; 57():27-31. PubMed ID: 28131729
[TBL] [Abstract][Full Text] [Related]
7. Ceftaroline as salvage therapy for complicated MRSA bacteremia: case series and analysis.
Bhowmick T; Liu C; Imp B; Sharma R; Boruchoff SE
Infection; 2019 Aug; 47(4):629-635. PubMed ID: 30955166
[TBL] [Abstract][Full Text] [Related]
8. Ceftaroline for meticillin-resistant Staphylococcus aureus bacteraemia: case series and review of the literature.
Polenakovik HM; Pleiman CM
Int J Antimicrob Agents; 2013 Nov; 42(5):450-5. PubMed ID: 23993067
[TBL] [Abstract][Full Text] [Related]
9. Use of ceftaroline after glycopeptide failure to eradicate meticillin-resistant Staphylococcus aureus bacteraemia with elevated vancomycin minimum inhibitory concentrations.
Paladino JA; Jacobs DM; Shields RK; Taylor J; Bader J; Adelman MH; Wilton GJ; Crane JK; Schentag JJ
Int J Antimicrob Agents; 2014 Dec; 44(6):557-63. PubMed ID: 25282169
[TBL] [Abstract][Full Text] [Related]
10. Antimicrobial salvage therapy for persistent staphylococcal bacteremia using daptomycin plus ceftaroline.
Sakoulas G; Moise PA; Casapao AM; Nonejuie P; Olson J; Okumura CY; Rybak MJ; Kullar R; Dhand A; Rose WE; Goff DA; Bressler AM; Lee Y; Pogliano J; Johns S; Kaatz GW; Ebright JR; Nizet V
Clin Ther; 2014 Oct; 36(10):1317-33. PubMed ID: 25017183
[TBL] [Abstract][Full Text] [Related]
11. Treatment strategies for persistent methicillin-resistant Staphylococcus aureus bacteraemia.
Lewis PO; Heil EL; Covert KL; Cluck DB
J Clin Pharm Ther; 2018 Oct; 43(5):614-625. PubMed ID: 30003555
[TBL] [Abstract][Full Text] [Related]
12. Short versus long duration of ceftaroline combination therapy and outcomes in persistent or high-grade MRSA bacteremia: A retrospective single-center study.
Cabanilla MG; Bernauer ML; Atallah LM; Briski MJ; Koury J; Thompson CM; Rodriguez CN; Jakeman B; Byrd TF
PLoS One; 2024; 19(5):e0304103. PubMed ID: 38768130
[TBL] [Abstract][Full Text] [Related]
13. When sepsis persists: a review of MRSA bacteraemia salvage therapy.
Kullar R; Sakoulas G; Deresinski S; van Hal SJ
J Antimicrob Chemother; 2016 Mar; 71(3):576-86. PubMed ID: 26565015
[TBL] [Abstract][Full Text] [Related]
14. Clinical Data on Daptomycin plus Ceftaroline versus Standard of Care Monotherapy in the Treatment of Methicillin-Resistant Staphylococcus aureus Bacteremia.
Geriak M; Haddad F; Rizvi K; Rose W; Kullar R; LaPlante K; Yu M; Vasina L; Ouellette K; Zervos M; Nizet V; Sakoulas G
Antimicrob Agents Chemother; 2019 May; 63(5):. PubMed ID: 30858203
[TBL] [Abstract][Full Text] [Related]
15. Multicenter Observational Study of Ceftaroline Fosamil for Methicillin-Resistant Staphylococcus aureus Bloodstream Infections.
Zasowski EJ; Trinh TD; Claeys KC; Casapao AM; Sabagha N; Lagnf AM; Klinker KP; Davis SL; Rybak MJ
Antimicrob Agents Chemother; 2017 Feb; 61(2):. PubMed ID: 27895012
[TBL] [Abstract][Full Text] [Related]
16. Methicillin-resistant Staphylococcus aureus epidural abscess treated with ceftaroline fosamil salvage therapy.
Bucheit J; Collins R; Joshi P
Am J Health Syst Pharm; 2014 Jan; 71(2):110-3. PubMed ID: 24375602
[TBL] [Abstract][Full Text] [Related]
17. The use of ceftaroline fosamil in methicillin-resistant Staphylococcus aureus endocarditis and deep-seated MRSA infections: a retrospective case series of 10 patients.
Lin JC; Aung G; Thomas A; Jahng M; Johns S; Fierer J
J Infect Chemother; 2013 Feb; 19(1):42-9. PubMed ID: 22797874
[TBL] [Abstract][Full Text] [Related]
18. Ceftaroline fosamil: a novel broad-spectrum cephalosporin with activity against methicillin-resistant Staphylococcus aureus.
Jorgenson MR; DePestel DD; Carver PL
Ann Pharmacother; 2011 Nov; 45(11):1384-98. PubMed ID: 22009993
[TBL] [Abstract][Full Text] [Related]
19. Salvage treatment for persistent methicillin-resistant Staphylococcus aureus bacteremia: efficacy of linezolid with or without carbapenem.
Jang HC; Kim SH; Kim KH; Kim CJ; Lee S; Song KH; Jeon JH; Park WB; Kim HB; Park SW; Kim NJ; Kim EC; Oh MD; Choe KW
Clin Infect Dis; 2009 Aug; 49(3):395-401. PubMed ID: 19569970
[TBL] [Abstract][Full Text] [Related]
20. A Mini-Review on Ceftaroline in Bacteremia Patients with Methicillin-Resistant
Lounsbury N; Reeber MG; Mina G; Chbib C
Antibiotics (Basel); 2019 Mar; 8(1):. PubMed ID: 30897759
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
